BioCentury | Jul 10, 2018
Distillery Therapeutics
Cancer
...In vitro , cell culture and mouse studies identified a SALL4-derived peptide inhibitor of the SALL4-RBBP4...
...as adjuvant therapy for high-risk HCC. TARGET/MARKER/PATHWAY: Spalt like transcription factor 4 (SALL4); retinoblastoma binding protein 4 (RBBP4; RBAP48...
...of Singapore, Singapore email: daniel.tenen@nus.edu.sg Claire Quang Brigham and Women's Hospital Harvard Medical School National University of Singapore Retinoblastoma binding protein 4 (RBBP4) (RBAP48) Spalt...
...as adjuvant therapy for high-risk HCC. TARGET/MARKER/PATHWAY: Spalt like transcription factor 4 (SALL4); retinoblastoma binding protein 4 (RBBP4; RBAP48...
...of Singapore, Singapore email: daniel.tenen@nus.edu.sg Claire Quang Brigham and Women's Hospital Harvard Medical School National University of Singapore Retinoblastoma binding protein 4 (RBBP4) (RBAP48) Spalt...